Thanks for the heads up with those links.
Today's news...
Monday September 18, 11:27 am Eastern Time
Press Release
NaPro BioTherapeutics Files Patent Infringement Suit Relating to TAXOL Against Bristol-Myers Squibb Corporation
BOULDER, Colo.--(BW HealthWire)--Sept. 18, 2000--NaPro BioTherapeutics, Inc. (Nasdaq: NPRO - news) today announced that it has filed a patent infringement suit, together with its licensee, Abbott Laboratories (NYSE: ABT - news), in the United States District Court for the District of Colorado against Bristol-Myers Squibb Corporation (NYSE: BMY - news).
The suit alleges infringement of U.S. Patent numbers 5,972,992 and 5,977,164 which relate to paclitaxel, the active ingredient in Bristol-Myers Squibb's anticancer drug, TAXOL®.
NaPro BioTherapeutics, Inc., headquartered in Boulder, Colorado, with additional manufacturing and plantation operations in British Columbia, Canada, is a biopharmaceutical company focused on the development, production and licensing of complex natural-product pharmaceuticals |
